Medtronic MiniMed Consumer CGMS PMA Supplement To Be Refiled In Dec.
This article was originally published in The Gray Sheet
Executive Summary
Medtronic MiniMed's proposed labeling for the consumer version of its continuous glucose monitoring system (CGMS) "will not be as aggressive" as the firm originally planned, President Terry Gregg said Sept. 25 at an institutional investor conference in Minneapolis.
You may also be interested in...
Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed
TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004
Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed
TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004
Biosensor Technology To Monitor Aging Processes Needed – NIH
The National Institute on Aging hopes to fund the development of non-invasive biosensor monitors to track the aging process, according to NIA Geriatrics Health Program Specialist Winifred Rossi